{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:11:24Z","timestamp":1793506284959,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ymthe.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T20:28:43Z","timestamp":1578601723000},"page":"709-722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":796,"title":["Immune Responses to Viral Gene Therapy Vectors"],"prefix":"10.1016","volume":"28","author":[{"given":"Jamie L.","family":"Shirley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ype P.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cox","family":"Terhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7213-998X","authenticated-orcid":false,"given":"Roland W.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.01.001_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","article-title":"Gene therapy","volume":"381","author":"High","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in\u00a0vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156652307782151452","article-title":"Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects","volume":"7","author":"Seiler","year":"2007","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib4","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","volume":"109","author":"Othman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib5","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/1873-3468.13696","article-title":"Innate immunity to adenovirus: lessons from mice","volume":"593","author":"Atasheva","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2020.01.001_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2016.08.017","article-title":"Adenovirus sensing by the immune system","volume":"21","author":"Atasheva","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.1226625","article-title":"Coagulation factor X activates innate immunity to human species C adenovirus","volume":"338","author":"Doronin","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.01.001_bib8","doi-asserted-by":"crossref","first-page":"1256070","DOI":"10.1126\/science.1256070","article-title":"Intracellular sensing of complement C3 activates cell autonomous immunity","volume":"345","author":"Tam","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.01.001_bib9","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood-2006-04-008532","article-title":"Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes","volume":"108","author":"Parker","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib10","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","article-title":"Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib11","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1002\/1873-3468.13649","article-title":"Interaction of adenovirus with antibodies, complement, and coagulation factors","volume":"593","author":"Allen","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2020.01.001_bib12","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1128\/JVI.79.23.14622-14631.2005","article-title":"Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1","volume":"79","author":"Cotter","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ni.2548","article-title":"Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21","volume":"14","author":"McEwan","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib14","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1128\/JVI.00050-16","article-title":"Coordinated neutralization and immune activation by the cytosolic antibody receptor TRIM21","volume":"90","author":"Fletcher","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib15","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/JVI.01392-12","article-title":"Circulating antibodies and macrophages as modulators of adenovirus pharmacology","volume":"87","author":"Khare","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib16","doi-asserted-by":"crossref","first-page":"10440","DOI":"10.1073\/pnas.1806314115","article-title":"TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination","volume":"115","author":"Bottermann","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.01.001_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.3107","article-title":"Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement","volume":"19","author":"Xu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib18","doi-asserted-by":"crossref","first-page":"e73296","DOI":"10.1371\/journal.pone.0073296","article-title":"The coxsackievirus and adenovirus receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP)","volume":"8","author":"Houri","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.01.001_bib19","doi-asserted-by":"crossref","first-page":"10841","DOI":"10.1128\/JVI.01425-15","article-title":"intracellular signaling and desmoglein 2 shedding triggered by human adenoviruses Ad3, Ad14, and Ad14P1","volume":"89","author":"Wang","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib20","doi-asserted-by":"crossref","first-page":"e1004035","DOI":"10.1371\/journal.ppat.1004035","article-title":"IL-1\u03b1 and complement cooperate in triggering local neutrophilic inflammation in response to adenovirus and eliminating virus-containing cells","volume":"10","author":"Di Paolo","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2020.01.001_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.immuni.2009.04.015","article-title":"Virus binding to a plasma membrane receptor triggers interleukin-1\u03b1-mediated proinflammatory macrophage response in\u00a0vivo","volume":"31","author":"Di Paolo","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2020.01.001_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymthe.2005.08.007","article-title":"Rapid Kupffer cell death after intravenous injection of adenovirus vectors","volume":"13","author":"Manickan","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature06664","article-title":"The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response","volume":"452","author":"Muruve","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.01.001_bib24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/mt.2012.277","article-title":"Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in\u00a0vivo","volume":"21","author":"Suzuki","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib25","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1128\/JVI.00500-16","article-title":"Diminished innate antiviral response to adenovirus vectors in cGAS\/STING-deficient mice minimally impacts adaptive immunity","volume":"90","author":"Anghelina","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib26","doi-asserted-by":"crossref","first-page":"eaav0758","DOI":"10.1126\/science.aav0758","article-title":"Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses","volume":"365","author":"Wang","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.01.001_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature18317","article-title":"A core viral protein binds host nucleosomes to sequester immune danger signals","volume":"535","author":"Avgousti","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.01.001_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2016.06.001","article-title":"Viral vectors as vaccine carriers","volume":"21","author":"Ertl","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib29","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.72.5.4212-4223.1998","article-title":"Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers","volume":"72","author":"Jooss","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib30","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1128\/jvi.70.10.7209-7212.1996","article-title":"Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs","volume":"70","author":"Yang","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/mthe.2000.0032","article-title":"Role of vector in activation of T\u00a0cell subsets in immune responses against the secreted transgene product factor IX","volume":"1","author":"Fields","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib32","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1126\/science.273.5283.1862","article-title":"CD40 ligand-dependent T\u00a0cell activation: requirement of B7-CD28 signaling through CD40","volume":"273","author":"Yang","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.01.001_bib33","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1128\/jvi.70.9.6370-6377.1996","article-title":"Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues","volume":"70","author":"Yang","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.omtm.2018.01.002","article-title":"Pharmacology of recombinant adeno-associated virus production","volume":"8","author":"Penaud-Budloo","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging issues in AAV-mediated in\u00a0vivo gene therapy","volume":"8","author":"Colella","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib36","article-title":"A molecular revolution in the treatment of hemophilia","author":"Butterfield","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib37","doi-asserted-by":"crossref","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.omtm.2019.08.011","article-title":"Safety of same-eye subretinal sequential readministration of AAV2-hRPE65v2 in non-human primates","volume":"15","author":"Weed","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/hgtb.2012.243","article-title":"Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy","volume":"24","author":"Louis Jeune","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2020.01.001_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.omtm.2019.05.014","article-title":"Prevalence of anti-adeno-associated virus immune responses in international cohorts of healthy donors","volume":"14","author":"Kruzik","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.omtm.2019.05.009","article-title":"Therapeutic hFIX activity achieved after single AAV5-hFIX treatment in hemophilia B patients and NHPs with pre-existing Anti-AAV5 NABs","volume":"14","author":"Majowicz","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.omtm.2019.04.004","article-title":"Threshold for pre-existing antibody levels limiting transduction efficiency of systemic rAAV9 gene delivery: relevance for translation","volume":"13","author":"Meadows","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.omtm.2019.03.006","article-title":"The impact of pre-existing immunity on the non-clinical pharmacodynamics of AAV5-based gene therapy","volume":"13","author":"Long","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib44","doi-asserted-by":"crossref","first-page":"194ra92","DOI":"10.1126\/scitranslmed.3005795","article-title":"Overcoming preexisting humoral immunity to AAV using capsid decoys","volume":"5","author":"Mingozzi","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/mt.2013.244","article-title":"Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.omtm.2018.02.003","article-title":"Influence of pre-existing anti-capsid neutralizing and binding antibodies on AAV vector transduction","volume":"9","author":"Fitzpatrick","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/humc.2017.146","article-title":"Safety of intradiaphragmatic delivery of adeno-associated virus-mediated alpha-glucosidase (rAAV1-CMV-hGAA) gene therapy in children affected by Pompe disease","volume":"28","author":"Corti","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib48","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1038\/s41467-018-06621-3","article-title":"Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration","volume":"9","author":"Meliani","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2020.01.001_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib50","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm1549","article-title":"CD8+ T-cell responses to adeno-associated virus capsid in humans","volume":"13","author":"Mingozzi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib51","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI36891","article-title":"Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors","volume":"119","author":"Pien","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.01.001_bib52","doi-asserted-by":"crossref","first-page":"15029","DOI":"10.1038\/mtm.2015.29","article-title":"AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes","volume":"2","author":"Hui","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib53","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib54","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","article-title":"Hemophilia B gene therapy with a high-specific-activity factor IX variant","volume":"377","author":"George","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib55","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib56","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ymthe.2019.10.005","article-title":"Liver gene therapy: reliable and durable?","volume":"27","author":"Herzog","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib57","article-title":"The effect of CpG sequences on capsid-specific CD8+ T\u00a0cell responses to AAV vector gene transfer","author":"Xiang","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2019000007","article-title":"Gene therapy for hemophilia","volume":"2019","author":"Nathwani","year":"2019","journal-title":"Hematology (Am. Soc. Hematol. Educ. Program)"},{"issue":"Suppl Supl1","key":"10.1016\/j.ymthe.2020.01.001_bib59","first-page":"95","article-title":"Whole Exome Sequencing of Patients Treated with Adeno- associated Virus Serotype 8- Factor IX (AAV8- FIX) Gene Therapy Reveals Potential Determinants of Persistent Transgene Expression","volume":"3","author":"Bilic","year":"2019","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.ymthe.2020.01.001_bib60","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2012-10-460733","article-title":"Engineered AAV vector minimizes in\u00a0vivo targeting of transduced hepatocytes by capsid-specific CD8+ T\u00a0cells","volume":"121","author":"Martino","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib61","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/hum.2011.053","article-title":"Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing \u03b11-antitrypsin: interim results","volume":"22","author":"Flotte","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib62","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1172\/JCI70314","article-title":"Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression","volume":"123","author":"Mueller","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.01.001_bib63","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/hum.2013.169","article-title":"Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPLS447X) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy","volume":"25","author":"Ferreira","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib64","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1182\/blood-2010-10-314518","article-title":"The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver","volume":"117","author":"Martino","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hep.24625","article-title":"Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors","volume":"55","author":"H\u00f6sel","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2020.01.001_bib66","doi-asserted-by":"crossref","first-page":"e120474","DOI":"10.1172\/jci.insight.120474","article-title":"Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction","volume":"3","author":"Shao","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2020.01.001_bib67","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1172\/JCI37607","article-title":"The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice","volume":"119","author":"Zhu","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.01.001_bib68","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000369273","article-title":"Unique roles of TLR9- and MyD88-dependent and -independent pathways in adaptive immune responses to AAV-mediated gene transfer","volume":"7","author":"Rogers","year":"2015","journal-title":"J.\u00a0Innate Immun."},{"key":"10.1016\/j.ymthe.2020.01.001_bib69","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1182\/blood-2016-11-751040","article-title":"Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T\u00a0cells","volume":"129","author":"Rogers","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib70","article-title":"Type I IFN sensing by cDCs and CD4+ T\u00a0cell help are both requisite for cross-priming of AAV capsid-specific CD8+ T\u00a0cells","author":"Shirley","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib71","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/mt.2012.101","article-title":"MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV","volume":"20","author":"Sudres","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib72","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1172\/JCI122372","article-title":"Exposure to wild-type AAV drives distinct capsid immunity profiles in humans","volume":"128","author":"Kuranda","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.01.001_bib73","doi-asserted-by":"crossref","first-page":"103682","DOI":"10.1016\/j.cellimm.2017.07.012","article-title":"Regulatory T\u00a0cells and TLR9 activation shape antibody formation to a secreted transgene product in AAV muscle gene transfer","volume":"342","author":"Herzog","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/hgtb.2019.013","article-title":"TLR9-activating CpG-B ODN but not TLR7 agonists triggers antibody formation to factor IX in muscle gene transfer","volume":"30","author":"Butterfield","year":"2019","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2020.01.001_bib75","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/JVI.01990-07","article-title":"Complement is an essential component of the immune response to adeno-associated virus vectors","volume":"82","author":"Zaiss","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib76","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ymthe.2019.01.004","article-title":"Anti-drug antibody responses impair prophylaxis mediated by AAV-delivered HIV-1 broadly neutralizing antibodies","volume":"27","author":"Gardner","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib77","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2019.02.005","article-title":"Adeno-associated virus delivery of anti-HIV monoclonal antibodies can drive long-term virologic suppression","volume":"50","author":"Martinez-Navio","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2020.01.001_bib78","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fmicb.2011.00244","article-title":"Prevention and reversal of antibody responses against factor IX in gene therapy for hemophilia B","volume":"2","author":"Nayak","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib79","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2014-09-599266","article-title":"Synergy between rapamycin and FLT3\u00a0ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg","volume":"125","author":"Biswas","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib80","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/mt.2009.150","article-title":"Strategies to modulate immune responses: a new frontier for gene therapy","volume":"17","author":"Arruda","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib81","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne\u2019s muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib82","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1073\/pnas.1617726114","article-title":"Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for \u03b1-1-antitrypsin deficiency","volume":"114","author":"Calcedo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.01.001_bib83","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41591-019-0594-0","article-title":"Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models","volume":"25","author":"Song","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib84","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.ymthe.2019.10.011","article-title":"Micro-utrophin therapy for Duchenne muscular dystrophy","volume":"27","author":"Duan","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib85","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1172\/JCI68205","article-title":"CpG-depleted adeno-associated virus vectors evade immune detection","volume":"123","author":"Faust","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.01.001_bib86","first-page":"3958","article-title":"Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T\u00a0cells in mice","volume":"117","author":"Lin","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.01.001_bib87","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/mt.2011.280","article-title":"Self-complementary AAVs induce more potent transgene product-specific immune responses compared to a single-stranded genome","volume":"20","author":"Wu","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-12-25","article-title":"Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B","volume":"12","author":"Rogers","year":"2014","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib89","doi-asserted-by":"crossref","first-page":"14013","DOI":"10.1038\/mtm.2014.13","article-title":"Development of gene transfer for induction of antigen-specific tolerance","volume":"1","author":"Sack","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib90","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/emmm.201302859","article-title":"Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies","volume":"5","author":"Markusic","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib91","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood-2007-02-073304","article-title":"Induction and role of regulatory CD4+CD25+ T\u00a0cells in tolerance to the transgene product following hepatic in\u00a0vivo gene transfer","volume":"110","author":"Cao","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib92","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/mt.2013.94","article-title":"The role of apoptosis in immune hyporesponsiveness following AAV8 liver gene transfer","volume":"21","author":"Faust","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib93","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in\u00a0vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.01.001_bib94","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood-2007-03-080093","article-title":"Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver","volume":"110","author":"Mingozzi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib95","doi-asserted-by":"crossref","first-page":"16083","DOI":"10.1038\/mtm.2016.83","article-title":"Dynamics of antigen presentation to transgene product-specific CD4+ T\u00a0cells and of Treg induction upon hepatic AAV gene transfer","volume":"3","author":"Perrin","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib96","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coi.2016.02.009","article-title":"Staying local-antigen presentation in the liver","volume":"40","author":"Knolle","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib97","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1182\/blood-2004-03-0847","article-title":"Induction of antigen-specific CD4+ T-cell anergy and deletion by in\u00a0vivo viral gene transfer","volume":"104","author":"Dobrzynski","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib98","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ymthe.2017.02.014","article-title":"The Balance between CD8+ T\u00a0cell-mediated clearance of AAV-encoded antigen in the liver and tolerance is dependent on the vector dose","volume":"25","author":"Kumar","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib99","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.omtm.2019.08.012","article-title":"Role of regulatory T\u00a0cell and effector T\u00a0cell exhaustion in liver-mediated transgene tolerance in muscle","volume":"15","author":"Poupiot","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib100","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/mt.2011.33","article-title":"Nonredundant roles of IL-10 and TGF-\u03b2 in suppression of immune responses to hepatic AAV-factor IX gene transfer","volume":"19","author":"Hoffman","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib101","doi-asserted-by":"crossref","first-page":"103728","DOI":"10.1016\/j.cellimm.2017.12.002","article-title":"Liver induced transgene tolerance with AAV vectors","volume":"342","author":"Keeler","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib102","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/atm.2019.05.02","article-title":"Liver depot gene therapy for Pompe disease","volume":"7","author":"Kishnani","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib103","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymthe.2017.09.001","article-title":"Gene therapy-induced antigen-specific Tregs inhibit neuro-inflammation and reverse disease in a mouse model of multiple sclerosis","volume":"26","author":"Keeler","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib104","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1182\/blood-2010-06-288001","article-title":"Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy","volume":"116","author":"Finn","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib105","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/hep.24230","article-title":"Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk","volume":"53","author":"M\u00e1trai","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2020.01.001_bib106","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/emmm.201302857","article-title":"Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice","volume":"5","author":"Annoni","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib107","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib108","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The neurotropic properties of AAV-PHP.B are limited to C57BL\/6J mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib109","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ymthe.2018.11.013","article-title":"AAV-mediated progranulin delivery to a mouse model of progranulin deficiency causes t\u00a0cell-mediated toxicity","volume":"27","author":"Amado","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib111","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.omtm.2018.12.009","article-title":"Engineering and design of chimeric antigen receptors","volume":"12","author":"Guedan","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib112","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.omtm.2017.03.005","article-title":"Immune modulatory cell therapy for hemophilia B based on CD20-targeted lentiviral gene transfer to primary B cells","volume":"5","author":"Wang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.omtm.2018.10.006","article-title":"Surface-engineered lentiviral vectors for selective gene transfer into subtypes of lymphocytes","volume":"12","author":"Frank","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib114","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.omtm.2019.03.003","article-title":"Highly efficient and selective CAR-gene transfer using CD4- and CD8-targeted lentiviral vectors","volume":"13","author":"Jamali","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib115","doi-asserted-by":"crossref","first-page":"eaav7325","DOI":"10.1126\/scitranslmed.aav7325","article-title":"Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates","volume":"11","author":"Milani","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib116","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1182\/blood-2006-10-049312","article-title":"In\u00a0vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance","volume":"109","author":"Brown","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib117","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/mt.2012.150","article-title":"A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade","volume":"20","author":"Agudo","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib118","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.coviro.2016.08.016","article-title":"Lentiviral vector interactions with the host cell","volume":"21","author":"Borsotti","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib119","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/hum.2010.085","article-title":"HIV-1-derived lentiviral vectors directly activate plasmacytoid dendritic cells, which in turn induce the maturation of myeloid dendritic cells","volume":"22","author":"Rossetti","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib120","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/JVI.01818-06","article-title":"Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9","volume":"81","author":"Pichlmair","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib121","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ni.2767","article-title":"The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids","volume":"15","author":"Agudo","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2020.01.001_bib122","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/mt.2013.299","article-title":"One microRNA controls both angiogenesis and TLR-mediated innate immunity to nucleic acids","volume":"22","author":"Rogers","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib123","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1126\/science.1240933","article-title":"Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses","volume":"341","author":"Gao","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.01.001_bib124","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2013.11.002","article-title":"The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells","volume":"39","author":"Lahaye","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2020.01.001_bib125","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ymthe.2019.03.008","article-title":"Lentiviral vector-based dendritic cell vaccine suppresses HIV replication in humanized mice","volume":"27","author":"Norton","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib126","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2016.12.004","article-title":"HIV-1 conserved mosaics delivered by regimens with integration-deficient DC-targeting lentiviral vector induce robust T\u00a0cells","volume":"25","author":"Wee","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib127","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nm1398","article-title":"Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer","volume":"12","author":"Brown","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib128","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1182\/blood-2007-03-078493","article-title":"A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice","volume":"110","author":"Brown","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib129","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1182\/blood-2009-04-214569","article-title":"In\u00a0vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T\u00a0cells and promotes immunologic tolerance","volume":"114","author":"Annoni","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.01.001_bib130","doi-asserted-by":"crossref","first-page":"289ra81","DOI":"10.1126\/scitranslmed.aaa3032","article-title":"Insulin B chain 9\u201323 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs","volume":"7","author":"Akbarpour","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib131","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.ymthe.2017.04.029","article-title":"A novel platform for immune tolerance induction in hemophilia A mice","volume":"25","author":"Merlin","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib132","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.omtm.2018.12.013","article-title":"Transcriptional targeting and microRNA regulation of lentiviral vectors","volume":"12","author":"Merlin","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib133","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.15252\/emmm.201708148","article-title":"Genome editing for scalable production of alloantigen-free lentiviral vectors for in\u00a0vivo gene therapy","volume":"9","author":"Milani","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2020.01.001_bib134","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.ymthe.2019.05.022","article-title":"Busulfan combined with immunosuppression allows efficient engraftment of gene-modified cells in a rhesus macaque model","volume":"27","author":"Uchida","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.omtm.2019.10.010","article-title":"Immunoresponse to gene-modified hematopoietic stem cells","volume":"16","author":"Drysdale","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib136","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ymthe.2019.04.014","article-title":"Targeting a pre-existing anti-transgene T\u00a0cell response for effective gene therapy of MPS-I in the mouse model of the disease","volume":"27","author":"Squeri","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib137","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ymthe.2019.06.002","article-title":"ERT degrades gene therapy for storage disorder","volume":"27","author":"Markusic","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.001_bib138","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.omtm.2018.01.011","article-title":"Platelet-targeted gene therapy for hemophilia","volume":"9","author":"Shi","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.01.001_bib139","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/mt.2013.197","article-title":"Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIXnull mice","volume":"22","author":"Chen","year":"2014","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620300022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620300022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T12:11:36Z","timestamp":1727698296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620300022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1525001620300022"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.01.001","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune Responses to Viral Gene Therapy Vectors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}